ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 2 of 2 Results
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Dr. Michael Simpson, Oak Ridge National Laboratory Corporate Fellow and Group Leader of the Nanofabrication Research Laboratory Group in the Center for Nanophase Materials Sciences (CNMS) at ORNL, has been appointed the next director of the UT-ORNL Joint Institute for Biological Sciences (JIBS). This appointment is in addition to his role at CNMS.